69552-8  Thromboelastography after addtion of heparinase panel - BloodThromboelastography after addtion of heparinase panel - BloodThromboelastography after addtion of heparinase panel: -: Pt: Bld: -:  

PANEL HIERARCHY  (view this panel in the LForms viewer)

  LOINC#   LOINC Name R/O/C  Cardinality  Ex. UCUM Units 
  69552-8   Thromboelastography after addtion of heparinase panel - BloodThromboelastography after addtion of heparinase panel - BloodThromboelastography after addtion of heparinase panel: -: Pt: Bld: -:    
       66756-8   Clotting time of Blood by Thromboelastography --after addition of heparinaseClotting time of Blood by Thromboelastography --after addition of heparinaseClotting time^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography R   min 
       66753-5   Clot formation [Time] in Blood by Thromboelastography --after addition of heparinaseClot formation [Time] in Blood by Thromboelastography --after addition of heparinaseClot formation^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography R   min 
       66750-1   Clot angle in Blood by Thromboelastography --after addition of heparinaseClot angle in Blood by Thromboelastography --after addition of heparinaseClot angle^after addition of heparinase: Angle: Pt: Bld: Qn: Thromboelastography R   deg 
       66755-0   Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinaseMaximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinaseMaximum clot firmness^after addition of heparinase: Len: Pt: Bld: Qn: Thromboelastography R   mm 
       66754-3   Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  
       85820-9   Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness reduction^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  
       85819-1   Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude +​ heparinaseClot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude +​ heparinaseClot firmness reduction^60M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  
       66752-7   Clot strength in Blood by Thromboelastography --after addition of heparinaseClot strength in Blood by Thromboelastography --after addition of heparinaseClot strength^after addition of heparinase: ArEnrg: Pt: Bld: Qn: Thromboelastography   dyn.s/cm5 
       66746-9   Specimen typeSpecimen typeSpecimen type: Type: Pt: Specimen: Nom: O    
       66749-3   Circulatory assist status [Identifier]Circulatory assist status [Identifier]Circulatory assist status: Prid: Pt: ^Patient: Nom: O    
 

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Thromboelastography after addtion of heparinase panel  Pt  Bld 
  Long Common Name:  Thromboelastography after addtion of heparinase panel - Blood
  Short Name:  TEG after heparinase pnl Bld
  Display Name:  Thromboelastography after addtion of heparinase panel (Bld)

TERM DEFINITION/DESCRIPTION(S)
  This panel is based on the Thrombelastography (TEG) Hemostasis System 5000 series (Hemoscope Corp). This non-invasive instrument is used to monitor and analyze the coagulation state of a blood sample to assess the patient's clinical hemostasis condition.

Coagulation evaluations are often used to assess trauma, organ transplantation cardiac surgery post-operative hemorrhage and/or thrombosis, or other cardiac procedures.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.COAG/Lab
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.42
  Order vs. Obs.: Order
  Status: Active

PARTS

Part Type    Part No.  Part Name   
Component   LP139947-8  Thromboelastography after addtion of heparinase panel 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7747-1 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  肝素酶添加后血栓弹力描记术组套:-:时间点:全血:-:肝素酶添加后血栓弹力描记术组套:-:时间点:全血:-:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  trombo-elastografie na toevoeging van heparinase panel:-:moment:bloed:-:trombo-elastografie na toevoeging van heparinase panel:-:moment:bloed:-:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Thromboelastography after addtion of heparinase panel:-:Pt:Bld:-:Thromboelastography after addtion of heparinase panel:-:Pt:Bld:-:Thromboélastographie après héparinase panel [-] Sang ; -
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Tromboelastografia dopo aggiunta di eparina, panel:-:Pt:Sangue:-:Tromboelastografia dopo aggiunta di eparina, panel:-:Pt:Sangue:-:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Тромбоэластография после добавления гепариназы панель:-:ТчкВрм:Кр:-:Тромбоэластография после добавления гепариназы панель:-:ТчкВрм:Кр:-:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Tromboelastografía después de la adición de heparinasa:Propiedades mixtas (sólo paneles):Punto temporal:Sangre:-:Tromboelastografía después de la adición de heparinasa:Propiedades mixtas (sólo paneles):Punto temporal:Sangre:-:

RELATED NAMES
  Blood Panl TEG after heparinase pnl
  COAGULATION Pnl WB
  Pan Point in time Whole blood
  PANEL.COAGULATION Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Thromboelastography after addtion of heparinase panel - Blood
  Shortname: TEG after heparinase pnl Bld
  Fully Specified Name: Thromboelastography after addtion of heparinase panel: -: Pt: Bld: -:
     
  Component Word Count: 6
  ID: 68868
  # of Panel Elements: 11
  Status (Raw): ACTIVE



Selected information about each LOINC that is part of this panel



66756-8   Clotting time of Blood by Thromboelastography --after addition of heparinaseClotting time of Blood by Thromboelastography --after addition of heparinaseClotting time^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clotting time^after addition of heparinase  Time  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clotting time of Blood by Thromboelastography --after addition of heparinase
  Short Name:  Clotting time Heparinase Bld TEG
  Display Name:  Clotting time after addition of heparinase TEG (Bld)

PART DEFINITION/DESCRIPTION(S)
  Part: Clotting time
  Time until 2 mm clot firmness has been achieved after the test has been started.
 
 
  Part: Clotting time
  Clotting time is the time required for a sample of blood to coagulate in vitro under standard conditions. There are various methods for determining the clotting time, including manual methods such as Lee White and Sukharev, thromboelastography, and heparin protamine titration.
 
 
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

OBSERVATION REQUIRED IN PANEL
Required

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.44
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: minutes

EXAMPLE ANSWERS
  numeric

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP15959-7  Clotting time 
     Challenge   LP40300-3  after addition of heparinase 
Property   LP6879-3  Time   [Time (e.g. seconds)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 
Fragments for synonyms   LP20917-8  Clotting 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝血时间^在添加肝素酶之后:时间:时间点:全血:定量型:血栓弹力描记术凝血时间^在添加肝素酶之后:时间:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stollingstijd^na toevoeging van heparinase:tijd:moment:bloed:kwantitatief:trombo-elastografiestollingstijd^na toevoeging van heparinase:tijd:moment:bloed:kwantitatief:trombo-elastografie
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Temps de coagulation^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:ThromboélastographieTemps de coagulation^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:Thromboélastographie
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Temps de coagulation^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:ThromboélastographieTemps de coagulation^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:Thromboélastographie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clotting time^after addition of heparinase:Time:Pt:Bld:Qn:ThromboelastographyClotting time^after addition of heparinase:Time:Pt:Bld:Qn:ThromboelastographyTemps de coagulation après héparinase [Temps] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Tempo di coagulazione^dopo aggiunta di eparinasi:Tempo:Pt:Sangue:Qn:TromboelastografiaTempo di coagulazione^dopo aggiunta di eparinasi:Tempo:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Tiempo de coagulación^Tras adición de heparinasa:Tiempo:Punto temporal:Sangre:Qn:TromboelastografÍaTiempo de coagulación^Tras adición de heparinasa:Tiempo:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtılaşma zamanı^eklenmesinden sonra, heparinaz:Süre:Zmlı:Kan:Kant:TromboelastografiPıhtılaşma zamanı^eklenmesinden sonra, heparinaz:Süre:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  Blood Quan Thrombelastography
  Clot Quant Thrombelastometry
  Clottable Quantitative WB
  COAGULATION Random Whole blood
  Coagulation time Rate  
  Point in time R-time  
  QNT TEG  

EXAMPLE UNITS
  Unit  Source Type
  min  EXAMPLE UCUM UNITS 
  minutes  ORIGINAL SUBMISSION 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  min 
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  minutes 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Clotting time of Blood by Thromboelastography --after addition of heparinase
  Shortname: Clotting time Heparinase Bld TEG
  Fully Specified Name: Clotting time^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 6
  ID: 62073
  Status (Raw): ACTIVE


66753-5   Clot formation [Time] in Blood by Thromboelastography --after addition of heparinaseClot formation [Time] in Blood by Thromboelastography --after addition of heparinaseClot formation^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot formation^after addition of heparinase  Time  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase
  Short Name:  CFT Heparinase Bld TEG
  Display Name:  Clot formation after addition of heparinase TEG (Bld) [Time]

PART DEFINITION/DESCRIPTION(S)
  Part: Clot formation
  Time for the formation of a stable clot (between 2mm and 20 mm of firmness)
 
 
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

OBSERVATION REQUIRED IN PANEL
Required

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.44
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: minutes

EXAMPLE ANSWERS
  numeric

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP69275-3  Clot formation 
     Challenge   LP40300-3  after addition of heparinase 
Property   LP6879-3  Time   [Time (e.g. seconds)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块形成^在添加肝素酶之后:时间:时间点:全血:定量型:血栓弹力描记术凝块形成^在添加肝素酶之后:时间:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselformatie^na toevoeging van heparinase:tijd:moment:bloed:kwantitatief:trombo-elastografiestolselformatie^na toevoeging van heparinase:tijd:moment:bloed:kwantitatief:trombo-elastografie
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Formation du caillot^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:ThromboélastographieFormation du caillot^Après ajout d'héparinase:Durée:Temps ponctuel:Sang:Quantitatif:Thromboélastographie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot formation^after addition of heparinase:Time:Pt:Bld:Qn:ThromboelastographyClot formation^after addition of heparinase:Time:Pt:Bld:Qn:ThromboelastographyTemps de formation du caillot après héparinase [Temps] Sang ; Numérique ; Thromboélastogramme
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Clot Formation Time HEPTEM
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Coagulo, formazione^dopo aggiunta di eparinasi:Tempo:Pt:Sangue:Qn:TromboelastografiaCoagulo, formazione^dopo aggiunta di eparinasi:Tempo:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Formación del coágulo^Tras adición de heparinasa:Tiempo:Punto temporal:Sangre:Qn:TromboelastografÍaFormación del coágulo^Tras adición de heparinasa:Tiempo:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtı oluşması^eklenmesinden sonra, heparinaz:Süre:Zmlı:Kan:Kant:TromboelastografiPıhtı oluşması^eklenmesinden sonra, heparinaz:Süre:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  Blood QNT Thrombelastography
  CFT Quan Thrombelastometry
  COAGULATION Quant WB
  Kinetics Quantitative Whole blood
  k-time Random  
  Point in time TEG  

EXAMPLE UNITS
  Unit  Source Type
  min  EXAMPLE UCUM UNITS 
  minutes  ORIGINAL SUBMISSION 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  min 
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  minutes 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase
  Shortname: CFT Heparinase Bld TEG
  Fully Specified Name: Clot formation^after addition of heparinase: Time: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 6
  ID: 62070
  Status (Raw): ACTIVE


66750-1   Clot angle in Blood by Thromboelastography --after addition of heparinaseClot angle in Blood by Thromboelastography --after addition of heparinaseClot angle^after addition of heparinase: Angle: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot angle^after addition of heparinase  Angle  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot angle in Blood by Thromboelastography --after addition of heparinase
  Short Name:  Clot angle Heparinase Bld TEG
  Display Name:  Clot angle after addition of heparinase TEG (Bld) [Angle]

PART DEFINITION/DESCRIPTION(S)
  Part: Clot angle
  Angle observed in thromboelasography tracing that represents the acceleration of build up of fibrin and cross-linking.
 
 
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

OBSERVATION REQUIRED IN PANEL
Required

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.44
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: degrees

EXAMPLE ANSWERS
  numeric

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129064-4  Clot angle 
     Challenge   LP40300-3  after addition of heparinase 
Property   LP6778-7  Angle 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块角度^在添加肝素酶之后:角度:时间点:全血:定量型:血栓弹力描记术凝块角度^在添加肝素酶之后:角度:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselhoek^na toevoeging van heparinase:hoek:moment:bloed:kwantitatief:trombo-elastografiestolselhoek^na toevoeging van heparinase:hoek:moment:bloed:kwantitatief:trombo-elastografie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot angle^after addition of heparinase:Angle:Pt:Bld:Qn:ThromboelastographyClot angle^after addition of heparinase:Angle:Pt:Bld:Qn:ThromboelastographyCaillot angle après héparinase [Angle] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Angolo coagulo^dopo aggiunta di eparinasi:Angolo:Pt:Sangue:Qn:TromboelastografiaAngolo coagulo^dopo aggiunta di eparinasi:Angolo:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Ángulo del coágulo^Tras adición de heparinasa:Ángulo:Punto temporal:Sangre:Qn:TromboelastografÍaÁngulo del coágulo^Tras adición de heparinasa:Ángulo:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtı açısı^eklenmesinden sonra, heparinaz:Açı:Zmlı:Kan:Kant:TromboelastografiPıhtı açısı^eklenmesinden sonra, heparinaz:Açı:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  Blood Quant Thrombelastometry
  COAGULATION Quantitative WB
  Point in time Random Whole blood
  QNT TEG  
  Quan Thrombelastography  

EXAMPLE UNITS
  Unit  Source Type
  deg  EXAMPLE UCUM UNITS 
  degrees  ORIGINAL SUBMISSION 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  deg 
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  degrees 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Clot angle in Blood by Thromboelastography --after addition of heparinase
  Shortname: Clot angle Heparinase Bld TEG
  Fully Specified Name: Clot angle^after addition of heparinase: Angle: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 6
  ID: 62066
  Status (Raw): ACTIVE


66755-0   Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinaseMaximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinaseMaximum clot firmness^after addition of heparinase: Len: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Maximum clot firmness^after addition of heparinase  Len  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinase
  Short Name:  MCF Heparinase Bld TEG
  Display Name:  Maximum clot firmness after addition of heparinase TEG (Bld) [Length]

PART DEFINITION/DESCRIPTION(S)
  Part: Maximum clot firmness
  Measure of the firmness of the clot, represented by the maximum amplitude which has been achieved during coagulation before fibrinolysis (reported in mm).
 
 
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

OBSERVATION REQUIRED IN PANEL
Required

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: mm

EXAMPLE ANSWERS
  numeric

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP69286-0  Maximum clot firmness 
     Challenge   LP40300-3  after addition of heparinase 
Property   LP6822-3  Len   [Length] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  最大凝块稳固性^在添加肝素酶之后:长度:时间点:全血:定量型:血栓弹力描记术最大凝块稳固性^在添加肝素酶之后:长度:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  maximale stolselstevigheid^na toevoeging van heparinase:lengte:moment:bloed:kwantitatief:trombo-elastografiemaximale stolselstevigheid^na toevoeging van heparinase:lengte:moment:bloed:kwantitatief:trombo-elastografie
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Fermeté maximum du caillot^Après ajout d'héparinase:Longueur:Temps ponctuel:Sang:Quantitatif:ThromboélastographieFermeté maximum du caillot^Après ajout d'héparinase:Longueur:Temps ponctuel:Sang:Quantitatif:Thromboélastographie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Maximum clot firmness^after addition of heparinase:Len:Pt:Bld:Qn:ThromboelastographyMaximum clot firmness^after addition of heparinase:Len:Pt:Bld:Qn:ThromboelastographyCaillot fermeté maximale après héparinase [Longueur] Sang ; Numérique ; Thromboélastogramme
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Maximal Clot Firmness HEPTEM
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Stabilità massima del coagulo^dopo aggiunta di eparinasi:Len:Pt:Sangue:Qn:TromboelastografiaStabilità massima del coagulo^dopo aggiunta di eparinasi:Len:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Firmeza maxima del coagulo^Tras adición de heparinasa:Longitud:Punto temporal:Sangre:Qn:TromboelastografÍaFirmeza maxima del coagulo^Tras adición de heparinasa:Longitud:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Maksimum pıhtı sertliği^eklenmesinden sonra, heparinaz:Uzn:Zmlı:Kan:Kant:TromboelastografiMaksimum pıhtı sertliği^eklenmesinden sonra, heparinaz:Uzn:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  Blood Point in time Thrombelastography
  CF QNT Thrombelastometry
  COAGULATION Quan WB
  Length Quant Whole blood
  MA Quantitative  
  Maximum amplitude Random  
  MCF TEG  

EXAMPLE UNITS
  Unit  Source Type
  mm  EXAMPLE UCUM UNITS 
  mm  ORIGINAL SUBMISSION 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  mm 
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  mm 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinase
  Shortname: MCF Heparinase Bld TEG
  Fully Specified Name: Maximum clot firmness^after addition of heparinase: Len: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 7
  ID: 62072
  Status (Raw): ACTIVE


66754-3   Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot firmness^30M after maximum clot amplitude after addition of heparinase  LenFr  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
  Short Name:  CF 30M p MA p hepase LenFr Bld TEG
  Display Name:  Clot firmness 30 Min p max clot amplitude + heparinase TEG (Bld) [Length fraction]

PART DEFINITION/DESCRIPTION(S)
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.61
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: %

EXAMPLE ANSWERS
  numeric

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129067-7  Clot firmness 
     Challenge   LP129068-5  30M after maximum clot amplitude after addition of heparinase   [30 min p max clot amplitude + heparinase] 
Property   LP6823-1  LenFr   [Length fraction] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块稳固性^在添加肝素酶后达到最大凝固幅度之后30分钟:长度分数:时间点:全血:定量型:血栓弹力描记术凝块稳固性^在添加肝素酶后达到最大凝固幅度之后30分钟:长度分数:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselstevigheid^30 minuten na maximum stollingsamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografiestolselstevigheid^30 minuten na maximum stollingsamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot firmness^30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyClot firmness^30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyCaillot fermeté T30min après amplitude maximale après héparinase [Fraction longueur] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Fermezza coagulo^30Minuti dopo massima ampiezza coagulo dopo aggiunta eparinasi:LenFr:Pt:Sangue:Qn:TromboelastografiaFermezza coagulo^30Minuti dopo massima ampiezza coagulo dopo aggiunta eparinasi:LenFr:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Firmeza del coágulo^30M después de amplitud máxima del coágulo , tras adición de heparinidasa.:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍaFirmeza del coágulo^30M después de amplitud máxima del coágulo , tras adición de heparinidasa.:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtı sertliği^30dk heparinaz eklenmesinden snr maksimum pıhtı büyüklüğü:UznFrak:Zmlı:Kan:Kant:TromboelastografiPıhtı sertliği^30dk heparinaz eklenmesinden snr maksimum pıhtı büyüklüğü:UznFrak:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  30M p MA p hepase Point in time TEG
  Blood QNT Thrombelastography
  CF Quan Thrombelastometry
  COAGULATION Quant WB
  Length Fraction Quantitative Whole blood
  Percent Random  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 
  ORIGINAL SUBMISSION 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 
  Source Type:  ORIGINAL SUBMISSION 
  Unit: 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:04 PM
  Attachment Units Required: N
  Long Common Name: Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
  Shortname: CF 30M p MA p hepase LenFr Bld TEG
  Fully Specified Name: Clot firmness^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 11
  ID: 62071
  Status (Raw): ACTIVE


85820-9   Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude +​ heparinaseClot firmness reduction^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase  LenFr  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
  Short Name:  CF reduc 30M p MA p hepase LenFr Bld TEG
  Display Name:  Clot firmness reduction 30 Min p max clot amplitude + heparinase TEG (Bld) [Length fraction]

TERM DEFINITION/DESCRIPTION(S)
  In this assay, the reduction of clot firmness (i.e., clot lysis), is measured 30 minutes after maximum clot amplitude is reached. Heparinase is added prior to starting the assay in order to eliminate interference by any heparin that is in the patient's sample.
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.61
  Last Updated in Version: 2.61
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129070-1  Clot firmness reduction 
     Challenge   LP129068-5  30M after maximum clot amplitude after addition of heparinase   [30 min p max clot amplitude + heparinase] 
Property   LP6823-1  LenFr   [Length fraction] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块稳固性降低^在添加肝素酶后达到最大凝固幅度之后30分钟:长度分数:时间点:全血:定量型:血栓弹力描记术凝块稳固性降低^在添加肝素酶后达到最大凝固幅度之后30分钟:长度分数:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselstevigheid afname^30 minuten na maximum stollingsamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografiestolselstevigheid afname^30 minuten na maximum stollingsamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyClot firmness reduction^30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyCaillot réduction de la fermeté T30min après amplitude maximale après héparinase [Fraction longueur] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Riduzione fermezza coagulo^30Minuti dopo massima ampiezza coagulo dopo aggiunta eparinasi:LenFr:Pt:Sangue:Qn:TromboelastografiaRiduzione fermezza coagulo^30Minuti dopo massima ampiezza coagulo dopo aggiunta eparinasi:LenFr:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Reduccion de la firmeza del coágulo^30M después de amplitud máxima del coágulo , tras adición de heparinidasa.:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍaReduccion de la firmeza del coágulo^30M después de amplitud máxima del coágulo , tras adición de heparinidasa.:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtı sertliğinin azaltılması^30dk heparinaz eklenmesinden snr maksimum pıhtı büyüklüğü:UznFrak:Zmlı:Kan:Kant:TromboelastografiPıhtı sertliğinin azaltılması^30dk heparinaz eklenmesinden snr maksimum pıhtı büyüklüğü:UznFrak:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  30M p MA p hepase Point in time Thrombelastography
  Blood QNT Thrombelastometry
  CF Quan WB
  CF reduc Quant Whole blood
  COAGULATION Quantitative  
  Length Fraction Random  
  Percent TEG  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:05 PM
  Long Common Name: Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
  Shortname: CF reduc 30M p MA p hepase LenFr Bld TEG
  Fully Specified Name: Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 12
  ID: 91289
  Status (Raw): ACTIVE


85819-1   Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude +​ heparinaseClot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude +​ heparinaseClot firmness reduction^60M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot firmness reduction^60M after maximum clot amplitude after addition of heparinase  LenFr  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase
  Short Name:  CF reduc 60M p MA p hepase LenFr Bld TEG
  Display Name:  Clot firmness reduction 60 Min p max clot amplitude + heparinase TEG (Bld) [Length fraction]

TERM DEFINITION/DESCRIPTION(S)
  In this assay, the reduction of clot firmness (i.e., clot lysis), is measured 60 minutes after maximum clot amplitude is reached. Heparinase is added prior to starting the assay in order to eliminate interference by any heparin that is in the patient's sample.
 
 

PART DEFINITION/DESCRIPTION(S)
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.61
  Last Updated in Version: 2.61
  Order vs. Obs.: Both
  Status: Active

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129070-1  Clot firmness reduction 
     Challenge   LP249020-1  60M after maximum clot amplitude after addition of heparinase   [60 min p max clot amplitude + heparinase] 
Property   LP6823-1  LenFr   [Length fraction] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块稳固性降低^在添加肝素酶及最大凝固幅度之后60分钟:长度分数:时间点:全血:定量型:血栓弹力描记术凝块稳固性降低^在添加肝素酶及最大凝固幅度之后60分钟:长度分数:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselstevigheid afname^60 minuten na maximum stolselamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografiestolselstevigheid afname^60 minuten na maximum stolselamplitude na toediening van heparinase:lengtefractie:moment:bloed:kwantitatief:trombo-elastografie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot firmness reduction^60M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyClot firmness reduction^60M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:ThromboelastographyCaillot réduction de la fermeté T60min après amplitude maximale après héparinase [Fraction longueur] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Riduzione fermezza coagulo^60Minuti dopo l'ampiezza massima raggiunta dal coagulo dopo aggiunta di eparanasi:LenFr:Pt:Sangue:Qn:TromboelastografiaRiduzione fermezza coagulo^60Minuti dopo l'ampiezza massima raggiunta dal coagulo dopo aggiunta di eparanasi:LenFr:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Reduccion de la firmeza del coágulo^?:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍaReduccion de la firmeza del coágulo^?:Longitud de la fraccion:Punto temporal:Sangre:Qn:TromboelastografÍa

RELATED NAMES
  60M p MA p hepase Point in time Thrombelastography
  Blood QNT Thrombelastometry
  CF Quan WB
  CF reduc Quant Whole blood
  COAGULATION Quantitative  
  Length Fraction Random  
  Percent TEG  

EXAMPLE UNITS
  Unit  Source Type
  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit: 

CHANGE HISTORY
  Change Type: ADD

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:05 PM
  Long Common Name: Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase
  Shortname: CF reduc 60M p MA p hepase LenFr Bld TEG
  Fully Specified Name: Clot firmness reduction^60M after maximum clot amplitude after addition of heparinase: LenFr: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 12
  ID: 91288
  Status (Raw): ACTIVE


66752-7   Clot strength in Blood by Thromboelastography --after addition of heparinaseClot strength in Blood by Thromboelastography --after addition of heparinaseClot strength^after addition of heparinase: ArEnrg: Pt: Bld: Qn: Thromboelastography  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Clot strength^after addition of heparinase  ArEnrg  Pt  Bld  Qn  Thromboelastography
  Long Common Name:  Clot strength in Blood by Thromboelastography --after addition of heparinase
  Short Name:  Clot strength Heparinase Bld TEG
  Display Name:  Clot strength after addition of heparinase TEG (Bld) [Energy/Area]

PART DEFINITION/DESCRIPTION(S)
  Part: Thromboelastography
  Thromboelastography (TEG) is a viscoelastic test of hemostasis. In TEG, whole blood is added to a cup in which a pin is suspended, the cup is rotated, and as the clot forms, the rotational force is transferred to the pin. The torsion of the pin is transformed into a graphic record of the physical shape of a clot during fibrin formation and lysis. TEG can provide information about the status of coagulation factors, platelet function and fibrinolysis in whole blood. TEG is primarily used for assessment of hemostasis after cardiopulmonary bypass, during liver transplant surgery, or hemorrhaging episodes. TEG parameters are also used as part of the guiding algorithms for plasma, platelet and cryoprecipitate transfusions.
  Copyright: Copyright © 1995-2009
 
 

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.44
  Order vs. Obs.: Observation
  Status: Active

SUBMITTER'S INFORMATION
  Submitted Units: Kd/sc

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129066-9  Clot strength 
     Challenge   LP40300-3  after addition of heparinase 
Property   LP6784-5  ArEnrg   [Energy/Area] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7057-5  Bld   [Blood] 
Scale   LP7753-9  Qn 
Method   LP69276-1  Thromboelastography 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  凝块强度^在添加肝素酶之后:能量/​面积:时间点:全血:定量型:血栓弹力描记术凝块强度^在添加肝素酶之后:能量/​面积:时间点:全血:定量型:血栓弹力描记术
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  stolselsterkte^na toevoeging van heparinase:energie/​oppervlakte:moment:bloed:kwantitatief:trombo-elastografiestolselsterkte^na toevoeging van heparinase:energie/​oppervlakte:moment:bloed:kwantitatief:trombo-elastografie
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Clot strength^after addition of heparinase:ArEnrg:Pt:Bld:Qn:ThromboelastographyClot strength^after addition of heparinase:ArEnrg:Pt:Bld:Qn:ThromboelastographyCaillot résistance après héparinase [Enregistrement arbitraire] Sang ; Numérique ; Thromboélastogramme
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Coagulo, forza^dopo aggiunta di eparinasi:ArEnrg:Pt:Sangue:Qn:TromboelastografiaCoagulo, forza^dopo aggiunta di eparinasi:ArEnrg:Pt:Sangue:Qn:Tromboelastografia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Resistencia del coágulo^Tras adición de heparinasa:Energia/​Área:Punto temporal:Sangre:Qn:TromboelastografÍaResistencia del coágulo^Tras adición de heparinasa:Energia/​Área:Punto temporal:Sangre:Qn:TromboelastografÍa
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Pıhtının sertliği^eklenmesinden sonra, heparinaz:AlanEnrj:Zmlı:Kan:Kant:TromboelastografiPıhtının sertliği^eklenmesinden sonra, heparinaz:AlanEnrj:Zmlı:Kan:Kant:Tromboelastografi

RELATED NAMES
  Aric energy Quan Thrombelastography
  Blood Quant Thrombelastometry
  COAGULATION Quantitative WB
  Point in time Random Whole blood
  QNT TEG  

EXAMPLE UNITS
  Unit  Source Type
  Kd/sc  ORIGINAL SUBMISSION 
  dyn.s/cm5  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  ORIGINAL SUBMISSION 
  Unit:  Kd/sc 
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  dyn.s/cm5 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:05 PM
  Attachment Units Required: N
  Long Common Name: Clot strength in Blood by Thromboelastography --after addition of heparinase
  Shortname: Clot strength Heparinase Bld TEG
  Fully Specified Name: Clot strength^after addition of heparinase: ArEnrg: Pt: Bld: Qn: Thromboelastography
     
  Component Word Count: 6
  ID: 62068
  Status (Raw): ACTIVE


66746-9   Specimen typeSpecimen typeSpecimen type: Type: Pt: Specimen: Nom:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Specimen type  Type  Pt  Specimen  Nom 
  Long Common Name:  Specimen type
  Short Name:  Specimen type
  Display Name:  Specimen type Nom (Spec)

OBSERVATION REQUIRED IN PANEL
Optional

BASIC ATTRIBUTES
  Class/Type: SPEC/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

EXAMPLE ANSWER LIST    (LL1859-9)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Amniotic fluid       LA30056-8  
  2       Blood       LA17759-4  
  3       Bone marrow       LA21012-2  
  4       Cerebrospinal fluid (CSF)       LA30055-0  
  5       Hair       LA30060-0  
  6       Kaolin modified blood       LA17761-0  
  7       Kaolin-heparinase modified blood       LA17762-8  
  8       Nail       LA30061-8  
  9       Nasopharyngeal       LA18005-1  
  10       Pericardial fluid       LA13476-9  
  11       Peritoneal fluid       LA13475-1  
  12       Plasma       LA17760-2  
  13       Respiratory       LA16975-7  
  14       Skin       LA4332-8  
  15       Synovial fluid       LA13477-7  
  16       Urine       LA30054-3  
  17       Stool       LA30063-4  

EXAMPLE ANSWERS
  Blood, Plasma, Kaolin modified blood, Kaolin-heparinase modified blood, etc.

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  67790-6 Thromboelastography panel - Blood
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  85735-9 Congenital rubella case report panel
  89724-9 Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers]
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129062-8  Specimen type 
Property   LP6886-8  Type 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7593-9  Specimen 
Scale   LP7750-5  Nom 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  标本类型:类型:时间点:标本:名义型:标本类型:类型:时间点:标本:名义型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  monstertype:type:moment:monster:nominaal:monstertype:type:moment:monster:nominaal:
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Type d'échantillon:Type:Temps ponctuel:Échantillon:Nominal:Type d'échantillon:Type:Temps ponctuel:Échantillon:Nominal:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Specimen type:Type:Pt:Specimen:Nom:Specimen type:Type:Pt:Specimen:Nom:Nature du prélèvement [Type] Prélèvement ; Résultat nominal
  German (AUSTRIA)  (From: ELGA, Austria)
 
  Material
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Campione, tipo:Tipo:Pt:Campione:Nom:Campione, tipo:Tipo:Pt:Campione:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Образца тип:Тип:ТчкВрм:Образец:Ном:Образца тип:Тип:ТчкВрм:Образец:Ном:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Tipo de muestra:Tipo:Punto temporal:Especimen:Nom:Tipo de muestra:Tipo:Punto temporal:Especimen:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Örnek tipi:Tip:Zmlı:Örnek:Snf:Örnek tipi:Tip:Zmlı:Örnek:Snf:

RELATED NAMES
  Nominal Spec  
  Point in time Typ  
  Random    

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:05 PM
  Attachment Units Required: N
  Long Common Name: Specimen type
  Shortname: Specimen type
  Fully Specified Name: Specimen type: Type: Pt: Specimen: Nom:
     
  Component Word Count: 2
  ID: 62062
  Status (Raw): ACTIVE


66749-3   Circulatory assist status [Identifier]Circulatory assist status [Identifier]Circulatory assist status: Prid: Pt: ^Patient: Nom:  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Circulatory assist status  Prid  Pt  ^Patient  Nom 
  Long Common Name:  Circulatory assist status [Identifier]
  Short Name:  Circ assist status Patient
  Display Name:  Circulatory assist status Nom

PART DEFINITION/DESCRIPTION(S)
  Part: Circulatory assist status
  Information about where the patient is in Hemostasis/Thrombosis spectrum.
 
 

OBSERVATION REQUIRED IN PANEL
Optional

BASIC ATTRIBUTES
  Class/Type: COAG/Lab
  First Released in Version: 2.38
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

EXAMPLE ANSWER LIST    (LL1641-1)  
 
Source: 3M Health Information Systems
  SEQ#        Answer        Answer ID    
  1       Ventricular assist device       LA16769-4  
  2       Baseline       LA16758-7  
  3       On pump       LA16762-9  
  4       Post protamine       LA16759-5  
  5       Unclamped       LA16764-5  

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  67790-6 Thromboelastography panel - Blood
  69552-8 Thromboelastography after addtion of heparinase panel - Blood
  

PARTS

Part Type    Part No.  Part Name   
Component   LP129065-1  Circulatory assist status 
Property   LP6850-4  Prid   [Presence or Identity] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  循环辅助状态:存在与否或特征标识:时间点:^患者:名义型:循环辅助状态:存在与否或特征标识:时间点:^患者:名义型:
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  circulatieondersteuning status:identificator:moment:^patiënt:nominaal:circulatieondersteuning status:identificator:moment:^patiënt:nominaal:
  French (FRANCE)  (From: ASIP Santé (Agence des systèmes d'information partagés de santé))
 
  Circulatory assist status:Prid:Pt:^Patient:Nom:Circulatory assist status:Prid:Pt:^Patient:Nom:Statut assistance circulatoire [Identification] Patient ; Résultat nominal
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Status di assistenza circolatoria:Prid:Pt:^Paziente:Nom:Status di assistenza circolatoria:Prid:Pt:^Paziente:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Циркуляторная поддержка статус:ПрИд:ТчкВрм:^Пациент:Ном:Циркуляторная поддержка статус:ПрИд:ТчкВрм:^Пациент:Ном:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Estado del sistema circulatorio:Presencia o identidad:Punto temporal:^paciente:Nom:Estado del sistema circulatorio:Presencia o identidad:Punto temporal:^paciente:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Dolaşım destek durumu:MevcKimlik:Zmlı:^Hasta:Snf:Dolaşım destek durumu:MevcKimlik:Zmlı:^Hasta:Snf:

RELATED NAMES
  Circ assist status Nominal  
  COAGULATION Point in time  
  Identity or presence Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 3:25:05 PM
  Attachment Units Required: N
  Long Common Name: Circulatory assist status [Identifier]
  Shortname: Circ assist status Patient
  Fully Specified Name: Circulatory assist status: Prid: Pt: ^Patient: Nom:
     
  Component Word Count: 3
  ID: 62065
  Status (Raw): ACTIVE